On February 7, 2013, Immunomedics, Inc., a Delaware corporation (the "Company"), issued a press release to report the Company's financial results for the quarter ended December 31, 2012. The full text of the press release is attached to this current report on Form 8-K as Exhibit 99.1.*

(d) Exhibits.

Exhibit No.   Description

99.1          Press Release of Immunomedics, Inc. dated February 7, 2013 reporting
              its financial results.

* The information in this Form 8-K shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.